Renalytix repays $1.06M of convertible bond with equity, principal now $14.84M

Renalytix plc

Repaid $1.06 million of convertible bond via 150,000 ordinary shares and 1,092,694 ADSs.
Remaining convertible bond principal reduced to $14.84 million.
Total shares outstanding after admission: 97,430,156 ordinary shares.
New ordinary shares expected to be admitted to AIM on October 19, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.